PRILOCAINE
Carpal Tunnel Syndrome
Francesco BonoSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Carpal Tunnel Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Haydarpasa Numune Training and Research Hospital | Phase 4 | BBB |
IBUPROFEN Universidad Europea de Madrid | Phase 4 | BB |
VITAMIN D Dr. Ayşe Güç | Phase 4 | BB |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Endo USA Inc., a Keenova Therapeutics Company | Phase 4 | BB |
Bont-A Francesco Bono | Phase 2 | CCC |
View all 9 →
Same molecule, other indications
PRILOCAINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →